Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer
In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX
Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks
NCI’s Goal To Increase Minority Participation In Trials, Sondik Says
UT Southwestern, M.D. Anderson Form Cancer Center In Dallas
NCI Scientists Immunize A Healthy BMT Donor Against Myeloma
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
